Page 136 - Read Online

El-Gazzar et al. Gadobenate dimeglumine dynamic MRI for early HCC detection

Financial support and sponsorship BI . The value of gadobenate dimeglumine-enhanced delayed phase
This study was supported by the National Liver MRI for characterization of hepatocellular nodules in the cirrhotic
liver. Invest Radiol 2008;43:202-10.
Institute, Menoufia University, Egypt. 12. Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y. Liver
cancer study group of Japan surveillance and diagnostic algorithm for
Conflicts of interest hepatocellular carcinoma proposed by the liver cancer study group of
There are no conflicts of interest. Japan: 2014 update. Oncology 2014;87 Suppl 1:7-21.
13. Lee JM, Park JW, Choi BI. 2014 KLCSG-NCC Korea practice
guidelines for the management of hepatocellular carcinoma: HCC
Patient consent diagnostic algorithm. Dig Dis 2014;32:764-77.
A written informed consent was obtained from all 14. Mitchell DG, Bruix J, Sherman M, Sirlin CB. LI-RADS (liver
participants in the study. imaging reporting and data system): summary, discussion, and
consensus of the LI-RADS management working group and future
directions. Hepatology 2015;61:1056-65.
Ethics approval 15. Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y, Okusaka
The study protocol was approved by the Institutional T, Miyayama S, Tsuchiya K, Ueshima K, Hiraoka A, Ikeda M,
Review Board (IRB) and local ethical committee of the Ogasawara S, Yamashita T, Minami T, Yamakado K; Liver Cancer
National Liver Institute, Menoufia University. Study Group of Japan. JSH Consensus-Based Clinical Practice
Guidelines for the Management of Hepatocellular Carcinoma: 2014
REFERENCES Update by the Liver Cancer Study Group of Japan. Liver Cancer
2014;3:458-68.
16. Bota S, Piscaglia F, Marinelli S, Pecorelli A, Terzi E, Bolondi L.
1. Bruix J, Sherman M. Management of hepatocellular carcinoma: an Comparison of international guidelines for noninvasive diagnosis of
update. Hepatology 2011:53:1020-2. hepatocellular carcinoma. Liver Cancer 2012;1:190-200.
2. Shen YC, Hsu C, Cheng CC, Hu FC, Cheng AL. A critical evaluation 17. Sanz-Cameno P, Trapero-Marugán M, Chaparro M, Jones EA,
of the preventive effect of antiviral therapy on the development Moreno-Otero R. Angiogenesis: from chronic liver inflammation to
of HCC in patients with chronic hepatitis C or B. Oncology hepatocellular carcinoma. J Oncol 2010;2010:272170.
2012;82:275-89. 18. Kim YK, Kim CS, Han YM, Park G. Detection of small
3. Stangovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic
M, Del Ninno E, Morabito A, Colombo M. The natural history of resonance imaging replace combining gadopentetatedimeglumine-
compensated cirrhosis due to hepatitis C virus: a 17-year cohort enhanced and superparamagnetic iron oxide-enhanced magnetic
study of 214 patients. Hepatology 2006; 34:1303-10. resonance imaging? Invest Radiol 2010;45:740-6.
4. Matsui O, Kobayashi S, Sanada J, Kouda W, Ryu Y, Kozaka K, 19. Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY. Added value
Kitao A, Nakamura K, Gabata T. Hepatocellular nodules in liver of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the
cirrhosis: hemodynamic evaluation (angiography-assisted CT) with diagnosis of hepatocellular carcinoma. Radiology 2010;255:459-66.
special reference to multi-step hepatocarcinogenesis. Abdom Imaging 20. Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai
2011;3:264-72. S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima
5. Kudo M. Early hepatocellular carcinoma: definition and diagnosis. K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S,
Liver Cancer 2013;2:69-72. Murakami T. Assessment of Gd-EOB-DTPA-enhanced MRI for
6. Llovet JM, Bruix J. Novel advancement in management of HCC and dysplastic nodules and comparison of detection sensitivity
hepatocellular carcinoma in 2008. J Hepatol 2008;48:S20-37. versus MDCT. J Gastroenterol 2012;47:1036-47.
7. Ricke J, Seidensticker M, Mohnike K. Noninvasive diagnosis of 21. Kim TK, Lee KH, Jang HJ, Jacks LM, Menesez RJ, Park SH, Yazdi
HCC in cirrhotic liver: current guidelines and future prospects for L, Sherman M, Khalil K. Analysis of gadobenatedimenglumine-
radiological imaging. Liver Cancer 2012;1:51-8. enhanced MR findings for characterizing small (1-2) hepatic nodules
8. Bolondi L, GaianiS, Celli N, Glofieri R, Grigioni WF, Leoni S, inpatients at high risk for hepatocellular carcinoma. Radiology
Venturi AM, Piscagila F. Characterization of small nodules in 2011;259:730-8.
cirrhosis by assessment of vascularity: the problem of hypovascular 22. Kim YK, Lee YH, Kwak HS, Kim CS, Han YM. Clinical implication
hepatocellular carcinoma. Hepatology 2005;42:27-34. of small (< 20 mm) enhancing hepatic nodules observed only during
9. Kim I, Kim MJ. Histological characteristics of HCC showing atypical three-dimensional gadobenatedimenglumine-enhanced arterial-phase
en-hancement pattern on 4-phase MDCT examination. Korean J MRI of the hepatitis B virus-induced mild cirrhosis. Clin Imaging
Radiol 2012;13:586-93. 2008;32:453-9.
10. Bartolozzi C, Crocetti L, Lenicioni R, Cioni D, Della Pina 23. Quaia E, Pizzolato R, De Paoli L, Angileri R, Ukmar M, Cova
C, Campani D. Biliary and reticuloendothelial impairment in MA. Arterial enhancing-only nodules less than 2 cm in diameter in
hepatocarcinogenesis: the diagnostic role of tissue-specific MR patients with liver cirrhosis: predictors of hepatocellular carcinoma
contrast media. Eur Radiol 2007;17:2519-30. diagnosis on gadobenatedimenglumine-enhanced MR imaging. J
11. Kim JI, Lee JM, Choi JY, Kim YK, Kim SH, Lee JY, Han JK, Choi Mag Reson Imaging 2013;37:892-902.

128 Hepatoma Research ¦ Volume 3 ¦ June 26, 2017